*E. coli* AlkB is a prototype of iron-containing dioxygenases that catalyze oxidative demethylation of nucleic acids and histones[@R3],[@R4]. Its human homologue ABH1 (also known as ALKBH1) demethylates 3-meC in DNA and RNA[@R7], ABH2 (ALKBH2) guards the mammalian genome against N^1^-methyl adenine (1-meA) damage[@R8], ABH3 (ALKBH3) may repair methylated RNA damage[@R9],[@R10], and FTO, which demethylates 3-meT and N^3^-methyl uracil (3-meU)[@R14],[@R15], is a key factor in regulating energy homeostasis and obesity[@R11]. In addition, within this iron(II)/α-ketoglutarate(αKG)-dependent subfamily, the JHDM proteins are engaged in the human epigenetic regulation by catalyzing the oxidative demethylation of methylated histones[@R4]. AlkB is quite versatile in that it can recognize and process three different types of base damages: (1) 3-meC and 1-meA, which formally bear a positive charge on the damaged nitrogen under physiological pH and are the most efficient substrates for AlkB[@R5],[@R6]; (2) neutral 3-meT and N^1^-methylated guanine (1-meG)[@R16]--[@R18]; and (3) cyclic adducts such as εA and 3,*N*^4^-ethenocytosine ([Supplementary Fig. 2](#SD2){ref-type="supplementary-material"})[@R19],[@R20]. Using a previously developed disulphide cross-linking approach[@R12],[@R13], we crystallized AlkB-dsDNA complexes containing 3-meC, 3-meT, and εA, and solved the structures to high resolutions ([Supplementary Table 1 and Supplementary Fig. 3](#SD2){ref-type="supplementary-material"}). In these structures, the catalytically essential iron(II) was replaced by manganese(II), which occupies the same binding site, but doesn't support catalysis[@R21],[@R22].

Comparisons of these structures, including a previously published 1-meA-containing structure (pdb code: 3BIE), provide hints on how AlkB recognizes a diverse range of substrates with different hydrogen-bonding capacities and base-dimensions. Of the four damaged bases, only one direct hydrogen bond is observed, which is between the side chain of Asp 135 and the exocyclic amine of 1-meA or 3-meC ([Supplementary Fig. 4](#SD2){ref-type="supplementary-material"}). Mutation of this residue yielded mutant proteins (Asp135Ala, Asp135Ser, or Asp135Asn) that display \~5--15% wild-type activity towards 1-meA at pH=7.0 ([Supplementary Fig. 5](#SD2){ref-type="supplementary-material"})[@R23]. Natural bond orbital (NBO) charge analysis suggests that the exocyclic amine bears a large portion of the delocalized positive charge for 1-meA and 3-meC ([Supplementary Fig. 6](#SD2){ref-type="supplementary-material"}), which agrees with the observation that charged lesions in category (1) are preferentially recognized by AlkB. For the neutral lesions (3-meT and εA) that instead possess a hydrogen bond acceptor at the equivalent position, such an interaction is replaced by water-mediated hydrogen bonds ([Supplementary Fig. 4](#SD2){ref-type="supplementary-material"}). On the contrary, 3-meT is a preferred substrate of FTO, and a hydrogen-bonding interaction between O4 of 3-meT and the amide nitrogen of Glu 234 has been observed in the crystal structure of FTO[@R24]; the disruption of this hydrogen bond results in the loss of the demethylation activity of FTO towards 3-meT. In the εA-containing structure, the cyclic adduct portion stacks against the side chain of Asp 133, which perhaps contributes to extra binding affinity of the lesioned base to the active site as compared to the repair product adenine ([Supplementary Fig. 4a](#SD2){ref-type="supplementary-material"}). On the other hand, substrates similar in size overlap well when bound in the active site, regardless of their hydrogen-bonding capacities ([Supplementary Fig. 7](#SD2){ref-type="supplementary-material"}). The final positions of a damaged purine and pyrimidine are consistently different, and are adjusted by AlkB so that the aberrant alkyl group is positioned towards the metal site for efficient catalysis ([Supplementary Fig. 8 and Supplementary Note](#SD2){ref-type="supplementary-material"}).

With several substrates covalently locked in the active site of AlkB, we set out to perform oxidation reactions in single crystals with a catalytically active iron centre ([Supplementary Fig. 1](#SD2){ref-type="supplementary-material"}). Performing enzymatic reactions in protein single crystals has been shown to be very effective in trapping and identifying unstable intermediates as well as elucidating reaction mechanisms[@R25]--[@R27]. The enzyme active sites provide nanoscale reaction vessels that allow isolation of otherwise transient intermediates.

Covalently linked AlkB-dsDNA complexes were crystallized with cofactors iron(II) and αKG under anaerobic conditions. Then, these crystals were exposed to air to initiate oxidation *in crystallo* ([Supplementary Fig. 1](#SD2){ref-type="supplementary-material"}). With the εA-containing DNA a (S,S)-22,23-glycol intermediate **1** was captured ([Fig. 2a](#F2){ref-type="fig"} and [Supplementary Fig. 9a](#SD2){ref-type="supplementary-material"}). The structure shows two newly formed hydroxyl groups that are involved in multiple hydrogen bonds: O26 forms a water-mediated interaction with Glu 136, and O24 hydrogen bonds directly to Arg 210 and succinate derived from αKG. The N6 atom of **1** forms indirect hydrogen bonds with the side chain of Asp 135 and the backbone amide of Lys 134, as also observed in the εA structure. Since O26 points away from the metal while O24 is within coordination distance to the iron (2.1 Å), we assigned O24 as the oxygen atom derived from O~2~ oxidation of εA to yield the epoxide intermediate, which then undergoes ring-opening by a water molecule attacking at C23 to afford the trans-glycol **1** ([Fig. 2a](#F2){ref-type="fig"} and [Supplementary Fig. 10a](#SD2){ref-type="supplementary-material"}). The observation of this glycol intermediate firmly confirms the epoxidation repair mechanism of εA by AlkB. Subsequent protonation at N6 of **1** is anticipated to break N1-C22 and N6-C23 bonds and eventually produce an intact adenine base ([Supplementary Fig. 10a](#SD2){ref-type="supplementary-material"}). Indeed, species with molecular weight corresponding to epoxide and glycol **1** were observed by mass spectrometry analysis[@R20]. Despite considerable efforts, we have yet to capture the epoxide intermediate in these crystals; the epoxide may not be as stable as **1** inside the enzymatic pocket of AlkB.

When 3-meT-containing crystals were exposed to air, the aberrant methyl group was oxidized to a hydroxymethyl group, which points towards the metal (3.6 Å) and hydrogen-bonds to Arg 210, Asn 120 and succinate ([Fig. 2b](#F2){ref-type="fig"} and [Supplementary Fig. 9b](#SD2){ref-type="supplementary-material"}). To our knowledge, this hemiaminal intermediate **2** is the first species of this type ever being observed in oxidative demethylation in biology. The mono-dentate succinate shifts away from the newly formed hydroxymethyl group in this hemiaminal structure compared to the glycol structure, which may reflect different recognition of these intermediates in the enzymatic pocket ([Supplementary Fig. 11](#SD2){ref-type="supplementary-material"}).

We next studied *in crystallo* oxidation of 3-meC, a preferred substrate of AlkB. Exposing crystals that contain 3-meC with air led to observation of extra electron density on the aberrant methyl group ([Supplementary Fig. 12](#SD2){ref-type="supplementary-material"}). The best fitting model was obtained after releasing certain geometry restraints on angles and bond lengths of the hydroxymethyl group in the 3-hydroxymethylcytosine (3-hmC) dictionary file during refinement ([Supplementary Table 2](#SD2){ref-type="supplementary-material"}). In this model **3**, C20-O21 distance was refined to \~1.2 Å, which is shorter than a typical C-O single bond (\~1.4 Å) ([Supplementary Fig. 13a](#SD2){ref-type="supplementary-material"}). While protein crystallography at this resolution cannot conclusively assign the exact structure of **3** ([Supplementary Fig. 13b](#SD2){ref-type="supplementary-material"}), we chemically synthesized a 3-meC analogue, 3-deaza-3-methyl cytosine (3-deazameC), to further investigate the 3-meC demethylation process ([Supplementary Fig. 14](#SD2){ref-type="supplementary-material"}). Crystals of AlkB-dsDNA containing 3-deazameC were also exposed to air, and in the resulting structure, an oxidized 3-deaza-3-hydroxymethyl cytosine **4** (3-deazahmC) was unambiguously observed ([Fig. 3a](#F3){ref-type="fig"} and [Supplementary Fig. 15](#SD2){ref-type="supplementary-material"}). Due to C3 substitution, 3-deazameC is neutral and its oxidized product **4** is a stable alcohol. We also demonstrate that 3-deazameC can be converted to **4** by AlkB *in vitro*, although with a lower activity compared to 3-meC ([Supplementary Fig. 16](#SD2){ref-type="supplementary-material"}), as expected chemically.

We then subjected the crystal structure containing **4** to combined quantum mechanical/molecular mechanical (QM/MM) minimizations ([Supplementary Note](#SD2){ref-type="supplementary-material"}). With a hydroxide ligand to iron(II) and a hydroxymethyl state of **4**, the optimized structure is stable and overlaps well with the crystal structure ([Fig. 3b](#F3){ref-type="fig"} and [Supplementary Fig. 17](#SD2){ref-type="supplementary-material"}). Replacing the C3 carbon in the optimized 3-deazahmC structure to a nitrogen atom causes spontaneous proton transfer from the hydroxymethyl group of **4** to the hydroxide ligand, resulting in an iron(II)-H~2~O state and a zwitterionic structure **5** ([Supplementary Fig. 18a](#SD2){ref-type="supplementary-material"}). In addition, an independent QM/MM minimization starting from the crystal structure with oxidized 3-meC **3** also leads to an iron(II)-H~2~O state, and the optimized structure agrees with the crystal structure ([Fig. 3c](#F3){ref-type="fig"} and [Supplementary Fig. 18b](#SD2){ref-type="supplementary-material"}). NBO analysis of the optimized structure containing **3** indicates that O21 bears a large negative partial charge, making the hemiaminal **3** actually a zwitterion ([Fig. 3c](#F3){ref-type="fig"}), which is virtually the same as the computed **5**. Moreover, starting from the optimized model of **3**, replacing N3 with a carbon atom yields a converged structure that is very similar to the optimized structure containing 3-deazahmC (**4**), with the key features---iron(II)-OH^−^ and the hydroxymethyl state---reproduced ([Supplementary Figs 18c and 19](#SD2){ref-type="supplementary-material"}). This *pK*a difference reflects the intrinsic chemical property of 3-meC, in which the cytosine ring bears a formal positive charge ([Supplementary Fig. 20](#SD2){ref-type="supplementary-material"}). Taken together, the evidence indicates that such a zwitterionic hemiaminal **3**, which explains the shortened C20-O21^−^ distance, is very likely an intermediate of 3-meC oxidative demethylation.

*E coli.* AlkB and its human homologues ABH2 and ABH3 prefer positively charged 1-meA and 3-meC to neutral 3-meT and 1-meG as substrates. With neutral 3-meT, the intermediate **2** is a relatively "stable" hemiaminal as compared with that derived from 3-meC ([Supplementary Fig. 10](#SD2){ref-type="supplementary-material"}). Protonation at the O4 atom of **2** initiates bond migration and decomposition of **2** to liberate formaldehyde and yield the final intact thymine base ([Supplementary Fig. 10b](#SD2){ref-type="supplementary-material"}). In contrast, hydroxylation of 3-meC yields 3-hmC, which readily deprotonates to form the more stable zwitterionic intermediate **3** ([Supplementary Fig. 10c](#SD2){ref-type="supplementary-material"}). Since the positively charged cytosine base is a much better leaving group than the neutral thymine at physiologic pH, the collapse of zwitterion **3** to cytosine and formaldehyde is expected to have a lower energetic barrier. This may partially explain the much faster repair of 1-meA and 3-meC by AlkB as compared to 1-meG and 3-meT.

The charge-bearing feature of 1-meA and 3-meC is reminiscent of a positively-charged trimethyl-lysine residue, the demethylation process of which and its dedicated enzymes are of great interest ([Supplementary Fig. 21](#SD2){ref-type="supplementary-material"})[@R4]. Within the AlkB family, FTO exhibits demethylation activity of neutral 3-meT and 3-meU, but not with 1-meA or 3-meC[@R14],[@R15]. Depending on the charge state of the substrate, intermediates similar to **2** or **3** could form during the demethylation processes catalyzed by these enzymes. The chemical nature of these intermediates can profoundly affect the reaction mechanism, reaction rate, and substrate specificity ([Supplementary Fig. 21](#SD2){ref-type="supplementary-material"}).

In summary, AlkB has the ability to work on a diverse range of substrates. Besides the DNA repair function that maintains the integrity of the genome[@R28]--[@R30], members from this protein family also play diverse roles in biology[@R9]--[@R11]. The capture and structural characterization of several different intermediates presented in this study dissect the differences in the mechanism used by these enzymes to oxidatively remove a methyl group from biological substrates. This work also serves as an example of *in crystallo* reaction that leads to the trapping and characterization of otherwise unstable intermediates to help fully elucidate the reaction mechanism.

METHODS SUMMARY {#S1}
===============

The disulphide cross-linked protein-DNA complexes were purified using Mono-Q anion exchange chromatography, and crystals were grown using hanging-drop vapour diffusion methods. Diffraction data were collected from cryo-preserved crystals at beamlines 23ID-B, 21ID-D, 19BM-D and 14BM-C at the Advanced Photon Source (APS), Argonne National Laboratory. The structures of AlkB-dsDNA complexes were solved by molecular replacement. Data collection and refinement parameters for all structures are given in [Supplementary Table 1](#SD2){ref-type="supplementary-material"}. Detailed procedures are presented in [Supplementary Information](#SD2){ref-type="supplementary-material"}.

**Full Methods** and any associated references are available in the online version of the paper at [www.nature.com/nature](http://www.nature.com/nature).

Methods {#S2}
=======

Oligonucleotide synthesis {#S3}
-------------------------

Oligonucleotides containing a disulfide-tethered cytosine and damaged bases (εA, 3-meT, and 3-meC) were prepared by incorporating the O~4~-triazolyl-dU-CE phosphoramidite (Glen Research, Inc.), etheno adenosine phosphoramidite, N^3^-methyl thymidine CED phosphoramidite, and N^3^-Methyl deoxy cytidine CED phosphoramidite (the latter three are purchased from ChemGenes Corp.) at the desired position during solid-phase synthesis[@R31]. All synthetic oligonucleotides were purified with reverse-phase HPLC.

Cross-linking and purification of the AlkB-dsDNA complexes {#S4}
----------------------------------------------------------

A truncated AlkB with deletion of the N-terminal 11 amino acids was cloned into a pET30a vector (Novagen) and overexpressed in *E. coli* BL21(DE3)[@R21]. The protein was purified following a previously described procedure[@R32]. The Ser 129 to Cys mutation was introduced using the QuikChange Site-Directed Mutagenesis Kit (Stratagene). Synthetic oligonucleotides (5′-TAGGTAAXAC\*CGT, where C\* is a disulfide-tethered cytosine and X stands for εA, 3-meT or 3-meC, and its complement strand 5′-AACGGTT_TACCT-3′, where "\_" stands for an abasic site) were prepared, annealed, and cross-linked to the S129C mutant AlkB as described[@R12]. The covalently linked AlkB-dsDNA complexes were purified using Mono-Q anion exchange chromatography (GE Healthcare), after which the buffer was exchanged to 100 mM NaCl, 10 mM Tris-HCl (pH 7.4), and the complexes were concentrated to 12--15 mg/mL before drops were set up.

Crystallization of the AlkB-DNA complexes containing Mn(II) and αKG {#S5}
-------------------------------------------------------------------

For the crystals grown under aerobic conditions, 1.0 mM MnCl~2~ (Mn(II) is able to occupy the Fe(II) site, but is incapable of catalysis) and 2.0 mM αKG were added to the complexes, and they were mixed in a 1:1 ratio with well solution containing 100 mM NaCl, 25 mM MgCl~2~, 100 mM cacodylate (pH 6.5) and 20--24% w/v PEG 8K or 4K. Crystals appeared after 2--4 days and were allowed to grow for several weeks. They were transferred into a cryo-protectant solution containing the reservoir solution plus 20% glycerol, and frozen in liquid nitrogen for X-ray data collection.

Conditions for *in crystallo* oxidation reactions {#S6}
-------------------------------------------------

All buffers and solutions used in crystallization trials were degassed with N~2~ for 30 min, and then transferred into an anaerobic chamber to equilibrate for at least 16 h before usage. The purified AlkB-dsDNA complexes were buffer-exchanged with degassed buffer at least four times, and then equilibrated in the anaerobic chamber before setting up crystallization trials. To set up drops, 1.0 mM (NH~4~)~2~Fe(SO~4~) and 2.0 mM αKG (the 50mM stock solution of which are always freshly prepared by dissolving (NH~4~)~2~Fe(SO~4~) and αKG solid in pre-equilibrated Milli-Q water in the anaerobic chamber) were added to the complexes (around 0.35\~0.45mM), and they were mixed in a 1:1 ratio with well solution containing 100 mM NaCl, 50 mM MgCl~2~, 100 mM cacodylate (pH 6.5) and 20--24% w/v PEG 8K or 4K. Crystals appeared after 2--4 days, and after crystals appeared they were exposed to air by opening the cover slides periodically, and were then immediately frozen in liquid N~2~ for X-ray data collection. Different time points of air exposure were sampled (2--4 min, 1--2 h, 5--6 h, 2 d, and 9 d). Since these crystals are sensitive to oxygen, drops were normally set up no more than 2 weeks in advance from the actual date of X-ray data collection.

Air exposure of the AlkB-DNA complex containing 3-meC, Mn(II) and αKG {#S7}
---------------------------------------------------------------------

Mn(II) has previously been shown to occupy the metal-binding site of AlkB, but is catalytically inactive[@R21],[@R22]. To be extra cautious, the *in crystallo* oxidation procedure for the Fe(II)/αKG-containing AlkB-dsDNA complex was performed for the Mn(II)/αKG-containing AlkB-dsDNA complex. The base lesion 3-meC was selected since it's the most efficient substrate of AlkB among the three damaged bases tested (εA, 3-meT, and 3-meC). Crystallization drops were set up under anaerobic conditions and cover slides were opened to expose these Mn(II)/αKG-containing crystals to air. Two independent batches of such crystals were tested and crystals were picked up after 2 h and 6 h air exposure, respectively. The structures of the 2 h- and 6 h-air-exposed crystals were solved to 1.92 Å and 1.98 Å, with R~work~/R~free~ of 17.9/22.5 and 18.9/24.3, respectively. The αKG cofactor has good electron density in both structures, indicating that Mn(II) is incapable of oxidation catalysis; the 3-meC base remains unmodified in both structures as well ([Supplementary Fig. 22](#SD2){ref-type="supplementary-material"}). Since these structures are the same as the structure 3O1M \[(Manganese/αKG)AlkB-DNA: 3-meC\], they are not deposited in the PDB database. In summary, these control experiments confirms AlkB-mediated *in crystallo* oxidation with Fe(II) as the catalytically essential metal ion.

Structure determination and refinement {#S8}
--------------------------------------

The AlkB-DNA complex structure was phased by molecular replacement (using Phaser)[@R33], using the previously published AlkB structure as a search model. The model was built by using COOT and refinement was carried out with the program REFMAC5 from the CCP4 suite[@R34],[@R35]. Simulated annealing omit maps were generated with Phenix[@R36]. Data collection and refinement parameters for all structures are given in [Supplementary Table 1](#SD2){ref-type="supplementary-material"}. Molecular graphics figures were prepared with PyMOL[@R37].

Ligand refinement and molecular modeling {#S9}
----------------------------------------

Regular damaged bases (εA, 3-meT, and 3-meC) were used as the initial model for the crystals obtained from *in crystallo* oxidation. Based on the resultant *F*~obs~ -- *F*~calc~ maps, appropriate modifications were modeled into the density to obtain the best fit of the data. Dictionaries for the glycol and hemiaminal intermediates were produced with Monomer Library Sketcher (in ccp4 suite). Occupancy of the additional atoms of the intermediate structures was \~100% based on the average temperature factors (that are similar to those of the rest of the base atoms) and the lack of *F*~obs~--*F*~calc~ density contoured at 3.0σ. Model bias associated with ligand refinement was evaluated by, in addition to simulated annealing omit maps using Phenix, examining omit difference maps. The extra atoms were removed from the final refined models, and resulting models were allowed to refine with at lease 10 cycles of restrained refinement. The resultant positive density in the difference *F*~obs~--*F*~calc~ maps was found to agree with the refined positions and structures of the base intermediates in the full models.

Reproducibility of the observed intermediates {#S10}
---------------------------------------------

The three intermediate structures reported here were also observed in several additional, independently refined structural datasets obtained from crystals prepared using the same procedure described (data not shown). These observations affirm a physical basis for the observed reactivity in crystalline form.

Synthetic protocols of compound XIII from IV {#S11}
--------------------------------------------

Compound **IV** was obtained according to literature methods and was directly isolated from the a-anomer by careful column chromatography[@R38].

### 4-Amino-1-(2\'-deoxy-β-D-erythro-pentofanosyl)-2-pyridone (X) {#S12}

To a solution of **IV** (200 mg, 0.418 mmol) in methanol (5 mL) was added 25% sodium methoxide (0.5 mL) dropwise and the resulting solution was stirred at rt for 30 min. Acetic acid was added dropwise to adjust PH=7. Removal of the solvents under reduced pressure and the residue was purified by silica gel chromatography, eluting with 5--15% MeOH in CH~2~Cl~2~, to give **X** (90.4 mg, 90%) as white foam. ^1^H NMR (500.1 MHz) (CD~3~OD) δ: 7.64 (d, *J*=7.5 Hz, 1H), 6.51 (t, *J*=6.5 Hz, 1H), 6.02 (d, *J*=7.5 Hz, 1H), 4.36 (m, 1H), 3.94 (m, 1H), 3.80 (dd, *J*=12.0, 4.0 Hz, 1H), 3.74 (dd, *J*=12.0, 4.0 Hz, 1H), 2.37 (m, 1H), 2.10 (m, 1H), 1.91 (s, 3H). ^13^C NMR (125.8 MHz) (CD~3~OD) δ: 162.8, 154.6, 130.0, 100.3, 87.1, 85.2, 70.8, 61.6, 41.0, 8.0.

### 4-Phenoxyacetylamido-1-(2\'-deoxy-β-D-erythro-pentofanosyl)-2-pyridone (XI) {#S13}

To a solution of **X** (82 mg, 0.34 mmol) in pyridine was added trimethylsilyl chloride (10 eq., 0.425 mL) and the mixture was stirred at rt for 2 h. Then phenoxyacetyl chloride (0.236 mL, 5 eq.) was added and the mixture was stirred for another 2 h. 1 mL ammonia hydroxide was added and stirred for 1 h. Removal of the solvents gave a residue, which was purified by silica gel chromatography, eluting with 3--10% MeOH in CH~2~Cl~2~, to give **XI** (100 mg, 78%) as white foam. ^1^H NMR (500.1 MHz) (CD~3~Cl+CD~3~OD) δ: 7.88 (d, *J*=8.0 Hz, 1H), 7.33 (m, 2H), 7.24 (d, *J*=8.0 Hz, 1H), 7.03 (m, 1H), 6.97 (d, *J*=8.5 Hz, 2H), 6.40 (t, *J*=6.0 Hz, 1H), 4.66 (s, 2H), 4.43 (m, 1H), 3.97 (m, 1H), 3.81 (m, 1H), 3.74 (m, 1H), 2.46 (m, 1H), 2.11 (m, 1H), 2.01 (s, 3H). ^13^C NMR (125.8 MHz) (CD~3~Cl+CD~3~OD) δ: 171.6, 166.7, 160.8, 147.7, 134.3, 133.7, 126.4, 118.5, 106.2, 91.4, 90.4, 74.3, 71.3, 65.4, 45.3, 13.5.

### 4-Phenoxyacetylamido-1-\[(5\'-*O*-(4,4\'-dimethoxytrityl)-2\'-deoxy-β-D-erythropentofanosyl\]-2-pyridone (XII) XI {#S14}

(90 mg, 0.24 mmol) was dissolved in pyridine (3 mL), and 4,4\'-dimethoxytrityl chloride (97.6 mg, 0.288 mmol) was added while stirring the solution. After being stirred overnight at room temperature, the reaction mixture was quenched with MeOH (1 mL), and stirred for an additional 5 min. The reaction mixture was concentrated to dryness under vacuum. Dichloromethane (100 mL) was added and washed with sodium hydrogen carbonate (5%, 50 mL) and brine and then dried over sodium sulfate. After the organic phase was concentrated to dryness, the residue was purified by silica gel chromatography, eluting with 1--3% MeOH in dichloromethane containing 0.2% Et~3~N, to give **XII** (145 mg, 91%) as a white foam. ^1^H NMR (500.1 MHz) (CD~3~CN) δ: 7.71 (d, *J*=7.5 Hz, 1H), 7.47 (d, *J*=7.5 Hz, 2H), 7.34 (m, 9H), 7.25 (m, 1H), 7.05 (m, 2H), 6.92 (d, *J*=6.5 Hz, 1H), 6.88 (m, 4H), 6.39 (m, 1H), 4.67 (s, 2H), 4.43 (m, 1H), 3.98 (m, 1H), 3.78 (m, 6H), 3.35 (m, 2H), 2.46 (m, 1H), 2.11 (m, 1H), 1.99 (s, 3H). ^13^C NMR (125.8 MHz) (CD~3~CN) δ: 162.0, 158.7, 157.3, 149.7, 144.9, 143.2, 135.9, 135.8, 130.08, 130.06, 129.9, 129.8, 128.1, 128.0, 127.0, 123.8, 122.0, 117.3, 116.8, 114.8, 114.2, 113.1, 101.3, 86.4, 85.9, 85.5, 70.2, 67.3, 63.0, 54.9, 41.2, 31.5, 9.6.

### 4-Phenoxyacetylamido-1-\[(5\'-*O*-(4,4\'-dimethoxytrityl)- 3\'-*O*-(2-cyanoethyl-*N,N*-diisopropyl)phosphoramidite-2\'-deoxy-β-D-erythro-pentofanosyl\]-2-pyridone (XIII) XII {#S15}

(140 mg, 0.21 mmol) was dissolved in dry CH~2~Cl~2~ (5 mL) and 1-methylimidazole (3.40 mg, 41.5 µmol). *N,N*-diisopropylethylamine (156 mg 0.84 mmol) was added to the stirring solution followed by 2-cyanoethyl *N,N*-(diisopropylchloro)-phosphoramidite (100 mg, 0.42 mmol). After being stirred at room temperature for 2 h, the reaction mixture was added to dichloromethane (5 mL) and the mixture was washed with 5% aqueous sodium bicarbonate and brine, dried over sodium sulfate and concentrated. The residue was purified by silica gel chromatography, eluting with 10--12% acetone in dichloromethane containing 0.2% Et~3~N, to give **XIII** (150 mg, 81%) as a white foam. ^31^P NMR (202.5 MHz) (CD~3~CN) δ: 148.3 and 148.4 ppm. HRMS for C~49~H~57~N~4~NaO~9~P, \[MNa\]^+^ 399.3761 (calcd.); 899.3753 (found).
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![Oxidative repair of damaged nucleic acid bases by AlkB\
Oxidative repair of εA, 3-meT, and 3-meC by AlkB with intermediates glycol **1**, hemiaminal **2,** and zwitterion **3** proposed in this study.](nihms235276f1){#F1}

![Intermediates trapped during *in crystallo* oxidation of εA and 3-meT\
**a**, Stereo views and electron density maps of the glycol intermediate **1** during εA repair. **b**, Stereo pairs and density maps of the hemiaminal intermediate **2** during the oxidation demethylation of 3-meT. The blue 2F~obs~-F~cal~ maps are contoured at 1.0σ and the green F~obs~-F~cal~ simulated-annealing omit maps were computed by removing extra atoms of intermediates (compared to the original substrates) and are contoured at 3.0σ. The extra atoms are shown in red. Hydrogen bonds are shown as dotted lines.](nihms235276f2){#F2}

![A zwitterionic intermediate 3 is proposed for the demethylation of 3-meC\
**a**, Oxidation of 3-deazameC in single crystals to yield 3-deazahmC, intermediate **4**. The density map and labels are generated and shown as in [Fig. 2](#F2){ref-type="fig"}. **b**, QM/MM calculated structure of **4**. **c**, Optimized structure of model **3** from the oxidized 3-meC crystal. For both calculated structures, carbon atoms are colored in cyan, nitrogen in blue, oxygen in red, iron in pink, and hydrogen in grey. Red NBO charges are labelled for several base atoms and key distances are marked in black (Å).](nihms235276f3){#F3}
